• Data Science, AI, Genomics, & Much More: A Preview of #BioIT18

    Bio-IT World | Whether you are coming to tour the exhibit hall, watch the three awards programs, listen to the plenary speakers, participate in the Hackathon, or dig deep into the latest science you are sure to have a full and fruitful three days during the 2018 Bio-IT World Conference & Expo.

    Apr 13, 2018

  • Scott Gottlieb Announces 3 New FDA Guidances Focused On NGS, In Vitro Diagnostic Development

    Diagnostics World News | Yesterday, FDA Commissioner Scott Gottlieb announced via Twitter new policies for the Administration he says are designed to "keep pace with fast-moving [next-generation sequencing] technologies." The three guidances focus solely on NGS and in vitro diagnostic development.

    Apr 13, 2018

  • HudsonAlpha’s Genomic Medicine Conference: Embracing A Brave New World

    Bio-IT World | Coinciding with the Institute’s 10-year anniversary, HudsonAlpha hosted their second Genomic Medicine Conference this week on their campus in Huntsville, Ala. For two and a half days researchers, geneticists and healthcare professionals told their stories about how genomic data has impacted their respective professions and how the data they have been collecting influences their patients.

    Apr 11, 2018

  • PerkinElmer Collaborates With Helix To Drive Innovation In Exome-Based Personal Genomics

    Bio-IT World Brief | PerkinElmer has announced a collaboration with Helix to develop and commercialize exome sequencing-based tests that will empower consumers to make proactive health management decisions. Tests developed as part of this collaboration will be available to customers of Helix’s expanding online marketplace for DNA-powered products.

    Apr 10, 2018

  • Dam Data: Health Systems, Machines, And Learning

    Bio-IT World Contributed Commentary | Increased use of electronic health records and other digital data has brought what amounts to a deluge of potential evidence, one that never ends. A “learning health system” can create the equivalent of a hydroelectric dam – a place to catch all of those raindrops in one place and release them in a coordinated, powerful way.

    Apr 9, 2018

  • Why Did Novartis Spend $9 Billion On Gene Therapy? CEO Says: A Journey To Focus On Data And Digital

    Forbes | Novartis announced it would buy gene therapy pioneer AveXis for $8.7 billion, giving the Swiss drug giant several treatments for rare diseases that work by inserting new DNA into patients' cells.

    Apr 9, 2018